Where does ResMed Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ResMed Corp. ranks #1,013 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ResMed Corp. hold?

ResMed Corp. holds 434 US utility patents granted between 2015 and 2025, spanning 51 technology areas.

What is ResMed Corp.'s Innovation Score?

ResMed Corp. has an Innovation Score of 65.1 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ResMed Corp.'s patent grant rate increasing or decreasing?

ResMed Corp.'s recent grant velocity is -90% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ResMed Corp.'s patents?

ResMed Corp.'s patents average 25.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ResMed Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ResMed Corp.

Q: What technology areas does ResMed Corp. focus on?

ResMed Corp.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 311 patents. Grants appear in 51 CPC subclasses total.

USPTO PatentsView assignee record - 434 granted patents across 51 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Resmed ranks #1,013 of 49,997 tracked US assignees by granted-patent volume, with 434 patents across 51 technology areas.

#1,013
of 49,997 US assignees by volume: Top 1%
by Innovation Score (65.1/100): 25.8
avg claims per patent: -90%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1013 · US Corporation #1,013 · 434 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 434 grants
TOP-DECILE #1,013/49,997
PHOTO-FINISH Akamai
CPC-WIDE A61M · 51 areas
INNOV-STRONG 65.1/100
CLAIMS-DENSE 25.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -90% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Akamai Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Motorola Solutions · near

65
Hologic · near

65
ResMed · this assignee

65
Southwest Jiaotong… · near

65
Lyft · near

65
3D Lighting… · lowest

7

What this shows Resmed's Innovation Score is 65.1/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Resmed's grant cadence moved

Between 2020–2024, ResMed Corp. received 38 grants versus 382 in 2015–2019 (-90% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2017 at 88 grants and bottomed in 2020 at 1. Lead class A61M accounts for 71.7% of the portfolio across 51 subclasses. Volume neighbours: Hansgrohe SE (#1,009) and Beijing Zitiao Network Technology Co., Ltd. (#1,017).

Resmed's three-year grant acceleration

From 2019–2021 to 2022–2024, ResMed Corp. moved from 55 to 34 grants (0.62x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,401. See the growth leaderboard.

Hansgrohe SE

435
Akamai

434
National Chiao Tu…

434
Panduit

434
Resmed ◀

434
Airbus Defence an…

433
Universal

433
Toyo Tire

432
Beijing Zitiao Ne…

431

What this shows ResMed holds 434 patents at rank #1,013, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ResMed

By rank, the assignees closest to #1,013 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in ResMed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ResMed, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (65 here).

Hologic, Inc. 65 Southwest Jiaotong University 65 Motorola Solutions, Inc. 65 Lyft, Inc. 65

Similar claim depth

Nearest assignees by average claims per patent (25.8 here).

Security First Corp. 25.8 avg Derrick Corporation 25.8 avg Knauf Insulation Sprl 25.9 avg ATI Properties LLC 25.8 avg

Resmed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

65 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ResMed Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	83	19.1%
2016	74	17.1%
2017	88	20.3%
2018	86	19.8%
2019	51	11.8%
2020	1	0.2%
2021	3	0.7%
2022	9	2.1%
2023	13	3.0%
2024	12	2.8%
2025partial year	14	3.2%

Which technologies does ResMed Corp. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 311

A61B - DIAGNOSIS; SURGERY; Identification 60

A62B - Devices, Apparatus OR Methods FOR Life-saving 41

Y10T - Technical Subjects Covered BY Former US Classification 32

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 28

H04W - Wireless Communication Networks 17

F04D - Non-positive-displacement Pumps 15

Y02A - Technologies FOR Adaptation TO Climate Change 15

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 14

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 12

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 9

H04B - Transmission 8

G06F - Electric Digital Data Processing 8

G06T - Image Data Processing OR Generation, IN General 8

F16L - PIPES; Joints OR Fittings FOR PIPES; Supports FOR Pipes, Cables OR Protective TUBING; Means FOR Thermal Insulation IN General 6

Top 15 of 51 technology areas

Where it ranks

Overall rank by patents

#1,013

of 49,997 tracked assignees

Innovation Score

65.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

ResMed Corp.'s patent record in context - here's where to go next.

ResMed Corp.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 71.7% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #1,013 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ResMed Corp. against Hansgrohe SE, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 65.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.